Look beyond BRCA for a more complete hereditary cancer risk picture
BRCA1 and BRCA2 are essential markers of hereditary breast cancer risk, but they're only part of the picture. Genes such as PALB2, CHEK2, ATM, and TP53 can also influence risk and help guide surveillance, risk-reduction, and treatment decisions.
For many eligible patients, current guidelines support multigene panel testing as a more comprehensive way to assess hereditary cancer risk. Labcorp's hereditary cancer testing portfolio, backed by genetic counseling resources, helps providers make confident, personalized care decisions.